ATE453381T1 - Nicht-pegylierte lang-zirkulierende liposome - Google Patents
Nicht-pegylierte lang-zirkulierende liposomeInfo
- Publication number
- ATE453381T1 ATE453381T1 AT03258252T AT03258252T ATE453381T1 AT E453381 T1 ATE453381 T1 AT E453381T1 AT 03258252 T AT03258252 T AT 03258252T AT 03258252 T AT03258252 T AT 03258252T AT E453381 T1 ATE453381 T1 AT E453381T1
- Authority
- AT
- Austria
- Prior art keywords
- liposomes
- phospholipid
- sucrose
- ammonium sulphate
- hydration
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 3
- 230000036571 hydration Effects 0.000 abstract 3
- 238000006703 hydration reaction Methods 0.000 abstract 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 2
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 2
- 239000001166 ammonium sulphate Substances 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 150000003904 phospholipids Chemical class 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 abstract 1
- 229930182558 Sterol Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 150000003432 sterols Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1101MU2002 | 2002-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE453381T1 true ATE453381T1 (de) | 2010-01-15 |
Family
ID=32500467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03258252T ATE453381T1 (de) | 2002-12-31 | 2003-12-31 | Nicht-pegylierte lang-zirkulierende liposome |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1435231B8 (enExample) |
| JP (1) | JP5355842B2 (enExample) |
| KR (2) | KR101133084B1 (enExample) |
| CN (1) | CN1756533B (enExample) |
| AT (1) | ATE453381T1 (enExample) |
| AU (1) | AU2003303368B2 (enExample) |
| BR (1) | BR0317882A (enExample) |
| CA (1) | CA2511464C (enExample) |
| DE (1) | DE60330745D1 (enExample) |
| DK (1) | DK1435231T3 (enExample) |
| EA (1) | EA008930B1 (enExample) |
| ES (1) | ES2337563T3 (enExample) |
| IL (1) | IL169364A (enExample) |
| MX (1) | MXPA05007102A (enExample) |
| NZ (1) | NZ540778A (enExample) |
| PT (1) | PT1435231E (enExample) |
| WO (1) | WO2004058140A2 (enExample) |
| ZA (1) | ZA200504850B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2152312B1 (en) * | 2007-05-16 | 2014-12-31 | KTB Tumorforschungsgesellschaft mbH | Low-viscous anthracycline formulation |
| WO2010113983A1 (ja) | 2009-03-30 | 2010-10-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | リポソーム組成物の製造方法 |
| PE20120923A1 (es) * | 2009-03-30 | 2012-08-27 | Eisai Randd Man Co Ltd | Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo |
| US20130337051A1 (en) * | 2011-03-01 | 2013-12-19 | To-Bbb Holding B.V. | Advanced active liposomal loading of poorly water-soluble substances |
| AU2015352685B2 (en) * | 2014-11-25 | 2020-09-17 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| WO2017188350A1 (ja) | 2016-04-28 | 2017-11-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 腫瘍の成長を抑制する方法 |
| MX394860B (es) * | 2016-09-27 | 2025-03-24 | Vertex Pharma | Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk). |
| ES3075649T3 (en) | 2019-07-26 | 2026-08-06 | Eisai R&D Man Co Ltd | Pharmaceutical composition for treating tumor |
| US11083705B2 (en) | 2019-07-26 | 2021-08-10 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition for treating tumor |
| CN116570775B (zh) * | 2023-05-16 | 2024-08-02 | 万瑞飞鸿(北京)医疗器材有限公司 | 一种药物涂层、血管支架及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| EP0153955A1 (en) * | 1983-09-06 | 1985-09-11 | Health Research, Inc. | Liposome delivery method for decreasing the toxicity of an antitumor drug |
| US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| CA1270198A (en) * | 1984-08-08 | 1990-06-12 | Marcel B. Bally | Encapsulation of antineoplastic agents in liposomes |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| CA1338702C (en) * | 1987-03-05 | 1996-11-12 | Lawrence D. Mayer | High drug:lipid formulations of liposomal- antineoplastic agents |
| JPH0720857B2 (ja) | 1988-08-11 | 1995-03-08 | テルモ株式会社 | リポソームおよびその製法 |
| IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| US6132763A (en) | 1988-10-20 | 2000-10-17 | Polymasc Pharmaceuticals Plc | Liposomes |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| ATE252372T1 (de) * | 1996-08-23 | 2003-11-15 | Sequus Pharm Inc | Liposome enthaltend cisplatin |
| CA2346879A1 (en) * | 1998-09-16 | 2000-04-27 | Alza Corporation | Liposome-entrapped topoisomerase inhibitors |
| KR20000061075A (ko) * | 1999-03-23 | 2000-10-16 | 린 중친 | 리포솜의 응집을 방지하기 위한 방법 및 조성물 |
| GB0111279D0 (en) * | 2001-05-10 | 2001-06-27 | Nycomed Imaging As | Radiolabelled liposomes |
-
2003
- 2003-12-31 DE DE60330745T patent/DE60330745D1/de not_active Expired - Lifetime
- 2003-12-31 DK DK03258252.0T patent/DK1435231T3/da active
- 2003-12-31 CN CN2003801100257A patent/CN1756533B/zh not_active Expired - Fee Related
- 2003-12-31 AU AU2003303368A patent/AU2003303368B2/en not_active Ceased
- 2003-12-31 BR BR0317882-0A patent/BR0317882A/pt not_active IP Right Cessation
- 2003-12-31 CA CA2511464A patent/CA2511464C/en not_active Expired - Fee Related
- 2003-12-31 NZ NZ540778A patent/NZ540778A/en not_active IP Right Cessation
- 2003-12-31 EP EP03258252A patent/EP1435231B8/en not_active Expired - Lifetime
- 2003-12-31 KR KR1020057012107A patent/KR101133084B1/ko not_active Expired - Fee Related
- 2003-12-31 MX MXPA05007102A patent/MXPA05007102A/es active IP Right Grant
- 2003-12-31 PT PT03258252T patent/PT1435231E/pt unknown
- 2003-12-31 WO PCT/IN2003/000424 patent/WO2004058140A2/en not_active Ceased
- 2003-12-31 KR KR1020117014172A patent/KR101171045B1/ko not_active Expired - Fee Related
- 2003-12-31 ES ES03258252T patent/ES2337563T3/es not_active Expired - Lifetime
- 2003-12-31 AT AT03258252T patent/ATE453381T1/de active
- 2003-12-31 EA EA200500850A patent/EA008930B1/ru not_active IP Right Cessation
- 2003-12-31 JP JP2004562836A patent/JP5355842B2/ja not_active Expired - Fee Related
-
2005
- 2005-06-14 ZA ZA200504850A patent/ZA200504850B/en unknown
- 2005-06-23 IL IL169364A patent/IL169364A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101171045B1 (ko) | 2012-08-03 |
| MXPA05007102A (es) | 2005-08-26 |
| CN1756533B (zh) | 2010-06-16 |
| EP1435231A1 (en) | 2004-07-07 |
| AU2003303368A1 (en) | 2004-07-22 |
| KR20110075051A (ko) | 2011-07-05 |
| JP2006513189A (ja) | 2006-04-20 |
| IL169364A0 (en) | 2007-07-04 |
| EP1435231B8 (en) | 2010-03-03 |
| EA200500850A1 (ru) | 2006-02-24 |
| NZ540778A (en) | 2008-04-30 |
| WO2004058140A3 (en) | 2004-10-28 |
| DK1435231T3 (da) | 2010-04-26 |
| ZA200504850B (en) | 2006-08-30 |
| EP1435231B1 (en) | 2009-12-30 |
| WO2004058140B1 (en) | 2004-12-16 |
| AU2003303368B2 (en) | 2010-06-17 |
| JP5355842B2 (ja) | 2013-11-27 |
| WO2004058140A2 (en) | 2004-07-15 |
| KR20050088233A (ko) | 2005-09-02 |
| CA2511464A1 (en) | 2004-07-15 |
| DE60330745D1 (de) | 2010-02-11 |
| BR0317882A (pt) | 2005-12-13 |
| IL169364A (en) | 2012-05-31 |
| ES2337563T3 (es) | 2010-04-27 |
| PT1435231E (pt) | 2010-04-08 |
| CN1756533A (zh) | 2006-04-05 |
| EA008930B1 (ru) | 2007-08-31 |
| KR101133084B1 (ko) | 2012-04-04 |
| HK1089946A1 (en) | 2006-12-15 |
| CA2511464C (en) | 2011-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60330745D1 (de) | Nicht-pegylierte lang-zirkulierende Liposome | |
| AR028504A2 (es) | Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial | |
| ITMI991803A0 (it) | Processo per la preparazione di formulazioni acquose per uso oftalmico | |
| EA200300457A1 (ru) | Кристаллический моногидрат, способ его получения и его применение для получения лекарственного средства | |
| DE3873528D1 (de) | Nystatin enthaltende liposome. | |
| ES2088385T3 (es) | Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido. | |
| ES2123284T3 (es) | Un sistema de suministro liposomico para agentes biologicamente activos. | |
| FI882692L (fi) | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi | |
| DE3864495D1 (de) | Amphotericin b-liposomzubereitung. | |
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| DK0689428T3 (da) | Forøget cirkulationseffektorpræparat og fremgangsmåde | |
| LU91650I2 (fr) | Saxagliptine et sels pharmaceutiquement acceptables de celle-ci, y compris l'hydrochlorure de saxagliptine - Onglyza-saxagliptin | |
| EE04344B1 (et) | Telmisartaani polümorfid, meetodid nende valmistamiseks ja nende kasutamine ravimi valmistamiseks | |
| AR049137A1 (es) | Formulacion de irinotecan en vesicula cerrada, para el tratamiento del cancer | |
| PT1282719E (pt) | Processo para a preparacao de esteres de di-hidroxilo e seus derivados | |
| ES2152324T3 (es) | Vesiculas lipidicas multilaminares bifasicas. | |
| IT8812585A0 (it) | Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle | |
| DE69902791D1 (de) | Polyoxypropylenpolyoxyethylen-vitamin e und seine herstellung | |
| DE60110057D1 (de) | Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung | |
| FI964936A0 (fi) | Bentsopyraaneja ja niiden käyttö terapeuttisina aineina | |
| FI883338A7 (fi) | Doksorubisiinihydrokloridin vesiliuoksia | |
| BR9917389A (pt) | Formulações tópicas compreendendo agentes de penetração na pele e o uso das mesmas | |
| AU8799001A (en) | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases | |
| FR2793490B1 (fr) | Procede de preparation du (1r,2s,4r)-(-)-2-[(2'-{n,n- dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]- bicyclo[2.2.1]-heptane et ses sels d'addition d'acide pharmaceutiquement acceptables | |
| RU2003104017A (ru) | Ингибиторы тромбина, содержащие аминоизохинолиновую группу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1435231 Country of ref document: EP |